| Literature DB >> 15820302 |
Suet-Ting Lau, Wai-Cho Yu, Ngai-Shing Mok, Ping-Tim Tsui, Wing-Lok Tong, Stella W C Cheng.
Abstract
SARS is a new infection in human. Patients recovering from SARS had palpitation in the form of sinus tachycardia. This study to identify the possible causes for the tachycardia excluded active disease, thyroid dysfunction, haematological, cardiac, autonomic and significant pulmonary defect at 2 months from onset of disease. The symptomatology was attributed to physical deconditioning and anxiety state. Physical and psychological fitness should be restored with rehabilitation.Entities:
Mesh:
Year: 2005 PMID: 15820302 PMCID: PMC7132412 DOI: 10.1016/j.ijcard.2004.06.022
Source DB: PubMed Journal: Int J Cardiol ISSN: 0167-5273 Impact factor: 4.164
Holter monitoring and pulmonary function test
| Sex | Age | Min HR | Max HR | Mean HR | HR variability SDNN (ms, | FEV1 % predicted | TLC % predicted | DLCO/VA % predicted | PFT interpretation | |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | M | 25 | 50 | 141 | 87 | 133 | 97 | 97 | 103 | Normal |
| 2 | F | 30 | 46 | 154 | 77 | 181 | 107 | 102 | 127 | Normal |
| 3 | F | 25 | 47 | 153 | 84 | 167 | 71 | 78 | 120 | Restrictive mild |
| 4 | M | 40 | 52 | 136 | 82 | 131 | 86 | 101 | 92 | Normal |
| 5 | F | 34 | 61 | 152 | 85 | 104 | 78 | 90 | 128 | Restrictive mild |
| 6 | F | 28 | 53 | 145 | 91 | 123 | 52 | 78 | 95 | Restrictive moderate |
| 7 | M | 33 | 50 | 137 | 87 | 118 | 79 | 85 | 79 | Restrictive mild |
| 8 | M | 49 | 51 | 142 | 83 | 137 | 120 | 121 | 128 | Normal |
| 9 | F | 26 | 49 | 129 | 77 | 135 | 84 | 114 | 123 | Normal |
| 10 | F | 39 | 51 | 116 | 79 | 103 | 109 | 121 | 97 | Normal |
| 11 | M | 62 | 53 | 114 | 70 | 97 | 98 | 123 | 88 | Normal |
| 12 | M | 36 | 57 | 123 | 83 | 111 | 112 | 91 | 110 | Normal |
| 13 | F | 25 | 55 | 163 | 85 | 147 | 107 | 102 | NA | Normal |
| 14 | M | 26 | 54 | 147 | 83 | 122 | 79 | 82 | 97 | Restrictive very mild |
| 15 | M | 47 | 50 | 135 | 82 | 140 | 91 | 103 | 103 | Normal |
Age=Age in years; Min HR=Minimum heart rate beats per minute; Max HR=Maximum heart rate beats per minute; SDNN=Standard deviation mean RR interval; FEV1%=Force expiratory volume in the first second; TLC%=Total lung capacity; DLCO/VA%=Diffusing capacity for carbon monoxide corrected for alveolar volume; PFT=Pulmonary function test.
Other factors
| CXR finding | Hb (g/dl) | LOS (days) | Discharge to PFT (days) | Complication | QOL | MFTE | |||
|---|---|---|---|---|---|---|---|---|---|
| Physical health domain | Psychological health domain | ||||||||
| I | II | ||||||||
| 1 | Mottling RLZ | 13 | 35 | 31 | AD | 75 | 63 | 69 | 20 |
| 2 | N | 12.8 | 25 | 36 | AD | *44 | *50 | *50 | 20 |
| 3 | Bilat shadowing | 13.3 | 54 | 21 | SP, CI | 69 | 69 | 75 | 19.4 |
| 4 | N | 14.5 | 37 | 14 | Pne | 56 | *44 | *50 | 19.7 |
| 5 | Bilat lower zone hazziness | 12.8 | 30 | 18 | ICU | 75 | 75 | 75 | 18.8 |
| 6 | Bilat lower zone hazziness | 12.9 | 39 | 23 | ICU | 88 | 81 | 81 | 19.5 |
| 7 | Bilat middle zone hazziness | 14.1 | 35 | 21 | ICU | 63 | 75 | 75 | 18.7 |
| 8 | Mild hazziness RLZ, LMZ | 13.1 | 21 | 51 | AD | 69 | 63 | 63 | 20 |
| 9 | N | 13.9 | 24 | 33 | AD | 63 | 56 | 56 | 19.6 |
| 10 | Bilat lower zone hazziness | 10.6 | 31 | 18 | UTI | 63 | 56 | 63 | 20 |
| 11 | N | 12.6 | 18 | 34 | 63 | *50 | *50 | 18.8 | |
| 12 | Bilat diffuse hazziness | 14.6 | 21 | 45 | CI | 75 | 63 | 63 | 19.8 |
| 13 | N | 13.6 | 21 | 21 | CI | 55 | *50 | 56 | 17.6 |
| 14 | Bilat M and LZ hazziness | 14.9 | 25 | 23 | ITP | 69 | *50 | 56 | 20 |
| 15 | Bilat lower zone hazziness | 13.5 | 29 | 29 | ICU | 63 | *25 | *38 | 19.2 |
Hb=Haemoglobin level; LOS=Length of hospital stay; Discharge to PFT=Discharge to day of pulmonary function test in days; ICU=ICU Care; ITP=Idiopathic thrombocytopenic purpura; UTI=Urinary tract infection; CI=Chest infection; CD=Anxiety depression; SP=Steroid psychosis; Pne=Pneumomediastinum and subcutaneous emphysema; QOL=Quality of life score; MFTE=Monitoring functional task evaluation; *=Score<50; QOL score—Normal>75; MFTE score—Normal>20.